Medy-Tox Inc.

KOSDAQ:A086900 Voorraadrapport

Marktkapitalisatie: ₩1.2t

Medy-Tox Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Hyun-Ho Jung

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO19.7%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement

Jul 19
Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement

Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Mar 31
Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Feb 27
Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

Apr 02
Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Feb 09
A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

Dec 18
Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

CEO

Hyun-Ho Jung (62 yo)

no data

Tenure

Mr. Hyun-Ho Jung serves as the Chief Executive Officer of Medy-Tox Inc. Mr. Hyun obtained Doctor of Science degree from Korea Advanced Institute of Science and Technology.